ATS/FSR Research Grant in Sarcoidosis is sponsored by American Thoracic Society (ATS) and Foundation for Sarcoidosis Research (FSR). One grant is available for early-career investigators interested in obstructive lung disease research. While specifically mentioning Sarcoidosis, it falls under the broader category of obstructive lung diseases, which can be relevant to COPD research.

American Thoracic Society | ATS Research Grants & Eligibility |… ATS Unrestricted & Emerging Voices in Health Research Grants The deadline to submit a letter of intent in the 2027 grant cycle has now passed. Up to six unrestricted grants, inclusive of one Emerging Voices in Health Research Grant, will be awarded in 2027 to early-career investigators. All applicants must first submit a letter of intent.

Individuals applying for the Emerging Voices in Health Research Grant may indicate their eligibility and interest within the letter of intent. International researchers are welcome to apply. Amount and duration varies.

ALA/ATS/CHEST Respiratory Health Equity Research Award $100,000 per year for two years One grant is available for early-career investigators addressing topics on improving clinical outcomes in preventing and/or treating lung disease in groups disproportionately impacted within the U.S. or globally. This grant is co-funded by the American Lung Association , ATS, and CHEST .

ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant One grant is available for investigators at any stage of their academic career interested in ACDMPV research. This grant is co-funded by the Alveolar Capillary Dysplasia Association and ATS. ATS/FSR Research Grant in Sarcoidosis One grant is available for early-career investigators interested in obstructive lung disease research.

This grant is co-funded by the Foundation for Sarcoidosis Research and ATS. ATS/PHA Early Career Award One grant is available for early-career investigators interested in pulmonary hypertension research who are likely to make a strong and sustained impact in PH research. This grant is co-funded by the Pulmonary Hypertension Association and ATS.

Grant Portfolio Opens January 20, 2026 Letters of Intent Due* March 11, 2026 Invitations to Applicants May 2026 Full Applications Due July 1, 2026 Award Notification September 2026 Grant Start Date January 2027 * Unrestricted/Emerging Voices in Health Research Grants only Applicants must be early-career investigators for all ATS Research Program grants unless otherwise stated.

ATS defines early-career investigators as individuals within 0-10 years of receiving their terminal degree (e.g., MD, PhD) or completing postdoctoral training, if applicable. For the current grant cycle, this means that you must have received your terminal degree or completed postdoctoral training no earlier than 2016. For MDs, postdoctoral training includes clinical sub-specialty training, but not research training.

For PhDs, this definition is inclusive of postdoctoral training. never having received a non-mentored grant ≥ $100,000 per year for at least two years, e.g., PI on a NIH R01 grant. Additional Eligibility Details In addition to early-career investigator status, the following eligibility requirements apply to all grants unless otherwise specified.

Review partner grant descriptions for requirements that may be specific to those opportunities.

be an ATS member at the time of application OR include at least one key personnel who is an ATS member to submit a letter of intent be an ATS member when the grant is awarded have completed their primary research training (PhD or sub-specialty fellowship) by January 1, 2026 have a firm commitment from their home institution for a faculty position by the time the grant is awarded in January 2027 have not received two ATS Research Program grants or be a current ATS Research Program grantee ATS considers exceptions to the early-stage investigator requirement for extenuating life circumstances such as parental or military leave.

Sub-specialty training is not considered an extenuating circumstance. If you have extenuating circumstances not related to sub-specialty training contact us before beginning a letter of intent or application.

ATS Emerging Voices in Health Research Grant Eligibility The ATS Emerging Voices in Health Research grant supports early-career researchers from groups that have faced challenges and obstacles to entry and advancement in medicine, research, and academic health professions.

Applications are encouraged from individuals who: • are first-generation college graduates • come from an economically disadvantaged background • are living with disabilities • may have lived experiences that reflect limited access to advancement opportunities Through this grant, ATS aims to build a more inclusive, representative, and supportive professional community that reflects the diversity of the populations it serves.

The ATS defines international applicants as individuals not working at a US-based institution OR someone who does not reside or work in the United States. ATS accepts submissions from international researchers unless otherwise specified. Review partner grant requirements, which may differ from ATS unrestricted and diversity grants.

ATS Policy on Grant Funding from Other Sources Simultaneous submission of grants with scientific overlap to other funding agencies is allowed. However, if multiple grants are funded, then the applicant must notify the Research Program within one month of formal award notification. A Scientific Grant Review Committee subcommittee will assess the degree of overlap.

In the case of significant scientific overlap, the applicant will have to choose between the ATS research grant and the other grant. Budgetary overlap is not allowed. Applicants holding active career development grants (e.g., K award) are eligible to receive ATS funding, but the projects must be scientifically distinct.

Applicants with K99/R00 awards are eligible only if they are within the K99 phase of the award and the project is scientifically distinct.